Grifols Sa Stock Fundamentals

GRF Stock  EUR 10.69  0.09  0.85%   
Grifols SA fundamentals help investors to digest information that contributes to Grifols SA's financial success or failures. It also enables traders to predict the movement of Grifols Stock. The fundamental analysis module provides a way to measure Grifols SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grifols SA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Grifols SA Company Profit Margin Analysis

Grifols SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Grifols SA Profit Margin

    
  0.01 %  
Most of Grifols SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grifols SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Grifols SA has a Profit Margin of 0.0115%. This is 100.1% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all Spain stocks is 100.91% lower than that of the firm.

Grifols SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.
Grifols SA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.85  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grifols SA is roughly  1.17 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Grifols SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Grifols SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Grifols Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grifols SA's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Grifols SA could also be used in its relative valuation, which is a method of valuing Grifols SA by comparing valuation metrics of similar companies.
Grifols SA is currently under evaluation in profit margin category among its peers.

Grifols Fundamentals

About Grifols SA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Grifols SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grifols SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grifols SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS S operates under Drug ManufacturersGeneral classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 24000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Grifols Stock

Grifols SA financial ratios help investors to determine whether Grifols Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.